Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the study record, indicating a new release of the page. This typically reflects minor edits or corrections to the record without changing the study details.SummaryDifference0.1%

- Check18 days agoChange DetectedThe site's software revision was updated from v3.6.0 to v3.6.2, signaling a minor platform update. This likely reflects backend improvements or bug fixes without altering the public study details shown on the page.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and an explicit recruitment status line ('No longer looking for participants'), and standardizes the Intervention/Treatment label while updating the page revision tag to v3.6.0.SummaryDifference0.5%

- Check40 days agoChange DetectedThe revision stamp on the page was updated from v3.5.4 to v3.5.5, signaling a new release of the page framework. No study details or visible content were changed.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous Revision: v3.5.3, indicating a minor update to the study record on the page.SummaryDifference0.1%

- Check76 days agoChange DetectedNo additions or deletions are detected in the supplied change data for this study page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.